1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Topics

Showing 230 results.

Thumbnail for Longer Survival With Tagraxofusp (TAG) vs Venetoclax (VEN) in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Results of a Real-World Analysis

AML - 610

Longer Survival With Tagraxofusp (TAG) vs Venetoclax (VEN) in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Results of a Real-World Analysis

Guru Subramanian Guru Murthy

Poster Presenter: Guru Subramanian Guru Murthy

Thumbnail for Cardiovascular Comorbidities and In-Hospital Mortality Among Patients Hospitalized With Leukemia: A National Inpatient Sample Analysis, 2018-2023

AML - 616

Cardiovascular Comorbidities and In-Hospital Mortality Among Patients Hospitalized With Leukemia: A National Inpatient Sample Analysis, 2018-2023

Ramsha Khan

Poster Presenter: Ramsha Khan

$Thumbnail for Long-term follow-up of pediatric/young adult patients with relapsed/refractory KMT2Ar acute leukemia treated with revumenib in AUGMENT-101$

AML - 623

Long-term follow-up of pediatric/young adult patients with relapsed/refractory KMT2Ar acute leukemia treated with revumenib in AUGMENT-101

Branko Cuglievan

Poster Presenter: Branko Cuglievan

Thumbnail for KIT Mutation-Driven Resistance to Venetoclax-Based Therapy in Acute Myeloid Leukemia: Superior Outcomes With Intensive Chemotherapy in Newly Diagnosed Patients

AML - 627

KIT Mutation-Driven Resistance to Venetoclax-Based Therapy in Acute Myeloid Leukemia: Superior Outcomes With Intensive Chemotherapy in Newly Diagnosed Patients

Ahmad Shafi Antar

Poster Presenter: Ahmad Shafi Antar

$Thumbnail for Revumenib Therapy Post-Hematopoietic Stem Cell Transplant for Patients With Relapsed/Refractory KMT2Ar, NPM1m, and NUP98r Acute Myeloid Leukemia: Post Hoc Analysis of Outcomes From AUGMENT-101$